Zydus Cadila gets USFDA nod for anti-diabetics tablets
Drug firm Zydus Cadila has received final nod from the US health regulator to sell anti-diabetics Glyburide and Metformin Hcl tablets in the American market.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Diabetes | Endocrinology | Fortamet | Glyburide | Health | Metformin | Pharmaceuticals